$HPS

Top Canadian Stocks to Buy for Growth in 2026

The article highlights two Canadian small caps: Hammond Power Solutions (TSX:HPS.A) and BQE Water (TSXV:BQE). Hammond reported Q1 2026 sales of $264.8M (+31.5% YoY), with adjusted EPS rising from $1.60 to $2.08 over 12 months and EBITDA to $41M. It expects ~$1.2B annual revenue capacity. BQE doubled 2025 sales to $35.5M and net income to $8.1M, with adjusted EBITDA $8.2M, citing new contracts and expanded services.

Original reporting
Published May 27, 2026, 4:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI May 27, 2026, 5:11 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Top Canadian Stocks to Buy for Growth in 2026 — source image
Decision brief

The 30-second read

$HPSBullishMed
01

Why it matters

For HPS, the trading thesis centers on demand for custom power transformers for data centers and a Mexico capacity ramp driving revenue/FCF. For BQE, the thesis centers on recurring mine water treatment services, contract wins, and a pipeline shift toward longer studies plus an aquatic toxicity lab.

02

Market read

The piece provides company-specific growth metrics and contract/backlog visibility that can influence near-term sentiment and valuation for these small-cap Canadian equities.

03

What to watch

Execution risk from manufacturing expansion (Mexico ramp for Hammond) and conversion timing from prefeasibility/feasibility studies into recurring contracts (BQE) are not quantified in the article.

Relevance 9/10Timing: Published 2026-05-27; useful for positioning ahead of upcoming earnings/contract updates, but not a fresh catalyst beyond the cited results.

Background

The article is a growth-focused roundup highlighting two Canadian small caps, citing record results and management commentary that 2026 could improve.

Company-level read

Ticker impact

$HPSBullishMedium confidence
Context

Hammond Power reported Q1 2026 sales up 31.5% YoY, rising adjusted EPS to $2.08, and growing backlog tied to data-center demand.

Expected impact

Bias toward upward price action if investors treat the growth/backlog visibility and Mexico ramp as credible; otherwise expect volatility around execution and margin sustainability.

Evidence & confidence

The piece cites multiple operating metrics (sales, adjusted EPS, EBITDA, backlog, capacity) but is still a promotional “top stocks” write-up rather than a primary earnings release.

Market effects

Supports the electrification/data-center capex and industrial services read-through: transformer demand and mine water treatment spending appear resilient.

Canadian small-cap sentiment may improve as investors rotate into TSX/TSXV names with US-linked growth (Hammond) and mining-linked recurring services (BQE).

Electrification and data-center buildouts are global themes, but the article’s evidence is company-specific rather than macro-only.

Counterpoint

“Top stocks to buy” framing may overstate durability; backlog/study pipelines can slip, and small caps can de-rate quickly if margins or conversion rates disappoint.

Key entities

  • Hammond Power Solutions

    Transformer manufacturer; Q1 2026 sales and profitability metrics cited, with backlog and Mexico expansion as growth drivers.

  • BQE Water

    Mine water treatment services/technology provider; 2025 growth and new contracts cited, with pipeline shift and lab expansion.

  • Canadian Royalties

    Named as a new contract counterparty for BQE’s plant-related work.

  • Britannia

    Named as a new contract counterparty for BQE’s plant-related work.

Related articles

Foreign Investors Dump ₩10 Trillion in Samsung Electronics, SK Hynix; Rotate into South Korean Substrate and Equipment Stocks

Foreign investors sold ₩10 trillion in Samsung Electronics and SK Hynix shares, shifting funds to South Korean substrate and equipment stocks tied to AI. Outflows from Samsung and SK Hynix totaled ₩10.5953 trillion. The KOSPI index fell to 6,008.81. Analysts note a rotation within the semiconductor sector rather than a full exit.

$ONCYMed

Cancer Drug Spending Is Headed Past $400 Billion as Colorectal and Pancreatic Cancers Move Up the Research Agenda

Global cancer drug spending reached $252B in 2024 and is forecast to exceed $400B by 2028, with the U.S. accounting for 46%. Several companies, including Oncolytics Biotech (ONCY), Revolution Medicines (RVMD), Eli Lilly (LLY), Genmab (GMAB), and Exelixis (EXEL), are advancing treatments for colorectal and pancreatic cancers. Oncolytics reported accelerating enrollment in a colorectal cancer study, while Revolution Medicines received FDA approval for a pancreatic cancer drug.

$NVDAMed

Nvidia Loses Ground to Huawei in China AI Chip Market

Nvidia's share of China's AI chip market fell to 34% in H1 2026, while Huawei gained 28% market share, according to IDC data. Nvidia's shipments declined 44% due to US export restrictions, while Huawei and other Chinese firms increased shipments. Non-GPU AI chips overtook GPUs in volume, with domestic firms leading this segment. IDC expects China's AI chip shipments to grow 19% in 2026, despite a 9% decline in GPU shipments.